As a leading learning platform for trends and issues confronting the pharmaceutical industry in Korea and the region, the Conference is an integral part of the event, and will give you a realistic assessment of the industry challenges & strategies.

2022 Conference Agenda

2022년 컨퍼런스 일정 (2022)
09.28(Wed) Time Title Organisation Speaker
Session 1 13:30 - 16:40 Seminar: Strategy for Health Functional Food Ministry of Food and Drug Safety
13:30 - 13:35 Greeting Speech Ministry of Food and Drug Safety 식품안전정책국장
13:35 - 13:40 Congratulatory Speech Korea Health Supplements Association Jung Myungsoo, President of KHSA
13:40 - 14:10 Health Functional Foods Act and policy directions Ministry of Food and Drug Safety, Health Functional Food Policy Division Haieun Lee, Deputy Director
14:10 - 14:40 Standards and Specifications for Health Functional Foods Ministry of Food and Drug Safety, Food Standard Division Hyung-Wook Chung, Senior Scientific Officer
14:40 - 14:50 Break Time
14:50 - 15:20 A procedure and evaluation of health functional food ingredients in Korea National Institute of Food and Drug Safety Evaluation Taehyung Yoon, Deputy Director
15:20 -15:50 Status of Technical Support for Commercialization of Health Functional Foods National Institute of Food and Drug Safety Evaluation Kwon Kwang-Il, Deputy Director
15:50 - 16:20 Inner beauty functional ingredient development with Korean mint extract Cosmax NBT Sang Woo Kim, SR. Executive Director
16:20 - 16:40 Q&A Ministry of Food and Drug Safety  

2022년 컨퍼런스 일정 (2022)
09.29(Thur) Time Title Organisation Speaker
Session 2 10:30 - 12:30 KDRA Innovation Policy Research Center (InnoPol) 2022 The 2nd Biohealth Policy Forum Korea Drug Research Association
10:20 - 10:30 Greeting Speech Center for Innovation Policy Young-Hyun Choi, President of InnoPol
10:30 - 11:50 Session 1. Key issues of Korea Bio-health industry's global growth strategy
10:30 - 10:50 Opportunities and Challenges in AI-Driven Drug Discovery and Development Dept. of Computer Scienceand Engineering, Korea Univ. Professor. Jae Woo Kang
10:50 - 11:10 AI and Big Data in New Drug Development Intlalinks Country Director. Sun Sik Kim
11:10 - 11:30 Application of AI and big data in drug discovery : case studies CIMPLRX CEO. Sung Jin Cho
11:30 - 11:50 Improvement of Drug Discovery Efficiency by AI, Big Data Pharminogen CEO. KIM Young Hoon
11:50 - 12:00 Break Time
12:00 - 12:30 Session 2. Panel Discussion
Suggestion new drug development policies based on Big Data/AI Center for Innovation Policy Young-Hyun Choi, President of InnoPol
12:30 Adjournment
Session 3 14:00 - 16:20 LBP(Live Biotherapeutic Products) Conference Session Korea Biomedicine Industry Association
14:00 - 15:20 Part 1. Microbiome Development Trends: A commercial perspective of microbiome
14:00 - 14:20 Current and Future Microbiome Trend: Development trends and its application in real practice Thermo Fisher Scientific Keun-Joon Park, Ph.D
14:20 - 14:40 Microbiome therapeutics: Global R&D Trend & Outlook Genome & Company (Genome & Co.) Youngjin Seo, CEO
14:40 - 15:00 국제 마이크로바이옴 규제현황 CJ Bioscience Lee Jehee
15:00 - 15:20 Trends and perspectives of microbiome R&D based on germ-free animals. POSTECH, Department of Life Sciences/Microbiome Core-Facility Kwang Soon Kim, Ph.D
15:30 - 16:20 Part 2. Microbiome: Exploring commercialization strategics - Panel discussion
15:30 - 16:15 Microbiome : Exploring commercialization strategics Panel Discussion  
16:15 - 16:20 Adjournment

2022년 컨퍼런스 일정 (2022)
09.30(Fri) Time Title Organisation Speaker
Session 4 10:30 - 12:30 KPTA Forum - How to proceed regulatory Innovation in the pharmaceutical Industry Korea Pharmaceutical Traders Association
Korea Pharmaceutical Test & Research Institute
10:30 - 11:00 Introduction of Pharmaceutical regulatory innovation in MFDS Ministry of Food and Drug Safety, Pharmaceutical Policy division Kim Sun young, Director
11:00 - 11:10 Break Time
11:10 - 11:40 Content and Submission of a post-approval Change Ministry of Food and Drug Safety, Approval Management Geuna Lee, Director
11:40 - 11:50 Break Time
11:50 - 12:20 Post-approval change control & Regulatory Innovation First-Up Solutions Corp. Kim Hodong, Representative Consultant

* The above timetable is subject to change without prior notice by the organiser or speakers
* All sessions will be presented in Korean only